Parallel Advisors’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-9,020
| Closed | -$887K | – | 3552 |
|
|
2025
Q2 | $887K | Buy |
9,020
+2,626
| +41% | +$248K | 0.02% | 448 |
|
|
2025
Q1 | $592K | Buy |
6,394
+5,225
| +447% | +$482K | 0.01% | 532 |
|
|
2024
Q4 | $106K | Sell |
1,169
-3,249
| -74% | -$298K | ﹤0.01% | 1236 |
|
|
2024
Q3 | $426K | Buy |
4,418
+728
| +20% | +$71K | 0.01% | 622 |
|
|
2024
Q2 | $339K | Buy |
3,690
+827
| +29% | +$76.7K | 0.01% | 661 |
|
|
2024
Q1 | $264K | Buy |
2,863
+2,528
| +755% | +$237K | 0.01% | 751 |
|
|
2023
Q4 | $31.8K | Buy |
335
+98
| +41% | +$9.15K | ﹤0.01% | 1665 |
|
|
2023
Q3 | $22.1K | Sell |
237
-13
| -5% | -$1.2K | ﹤0.01% | 1786 |
|
|
2023
Q2 | $22.9K | Buy |
250
+42
| +20% | +$3.45K | ﹤0.01% | 1788 |
|
|
2023
Q1 | $15.3K | Buy |
208
+11
| +6% | +$952 | ﹤0.01% | 1952 |
|
|
2022
Q4 | $16.5K | Sell |
197
-2
| -1% | -$180 | ﹤0.01% | 1795 |
|
|
2022
Q3 | $19K | Sell |
199
-16
| -7% | -$1.91K | ﹤0.01% | 1693 |
|
|
2022
Q2 | $23K | Sell |
215
-27
| -11% | -$3.45K | ﹤0.01% | 1594 |
|
|
2022
Q1 | $42K | Sell |
242
-44
| -15% | -$6.57K | ﹤0.01% | 1363 |
|
|
2021
Q4 | $46K | Buy |
286
+39
| +16% | +$6.27K | ﹤0.01% | 1363 |
|
|
2021
Q3 | $37K | Buy |
247
+68
| +38% | +$14.1K | ﹤0.01% | 1414 |
|
|
2021
Q2 | $44K | Sell |
179
-26
| -13% | -$6.82K | ﹤0.01% | 1299 |
|
|
2021
Q1 | $54K | Buy |
205
+10
| +5% | +$2.82K | ﹤0.01% | 1139 |
|
|
2020
Q4 | $57K | Buy |
195
+17
| +10% | +$4.36K | ﹤0.01% | 1044 |
|
|
2020
Q3 | $42K | Sell |
178
-14
| -7% | -$3.18K | ﹤0.01% | 1127 |
|
|
2020
Q2 | $38K | Hold |
192
| – | – | ﹤0.01% | 1145 |
|
|
2020
Q1 | $35K | Buy |
192
+47
| +32% | +$8.36K | ﹤0.01% | 1059 |
|
|
2019
Q4 | $24K | Hold |
145
| – | – | ﹤0.01% | 1308 |
|
|
2019
Q3 | $19K | Buy |
145
+13
| +10% | +$1.69K | ﹤0.01% | 1366 |
|
|
2019
Q2 | $16K | Hold |
132
| – | – | ﹤0.01% | 1376 |
|
|
2019
Q1 | $16K | Hold |
132
| – | – | ﹤0.01% | 1305 |
|
|
2018
Q4 | $15K | Hold |
132
| – | – | ﹤0.01% | 1164 |
|
|
2018
Q3 | $16K | Hold |
132
| – | – | ﹤0.01% | 1232 |
|
|
2018
Q2 | $11K | Hold |
132
| – | – | ﹤0.01% | 1293 |
|
|
2018
Q1 | $8K | Hold |
132
| – | – | ﹤0.01% | 1350 |
|
|
2017
Q4 | $7K | Hold |
132
| – | – | ﹤0.01% | 1413 |
|
|
2017
Q3 | $7K | Hold |
132
| – | – | ﹤0.01% | 1408 |
|
|
2017
Q2 | $6K | Hold |
132
| – | – | ﹤0.01% | 1486 |
|
|
2017
Q1 | $8K | Hold |
132
| – | – | ﹤0.01% | 1296 |
|
|
2016
Q4 | $6K | Buy |
+132
| New | +$5.61K | ﹤0.01% | 1283 |
|
Other funds holding AMED
IA
MCI
HNB
Parallel Advisors's AMED Position: Q3 2025 in Review
Parallel Advisors sold out of Amedisys (AMED) in Q3 2025, closing a stake of 9,020 shares — an estimated $887K sold.
Parallel Advisors first reported a position in AMED in Q4 2016 and held it in 35 quarters. The position peaked at $887K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- Parallel Advisors reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- Parallel Advisors sold 9,020 Amedisys shares in Q3 2025, an estimated $887K.
- Parallel Advisors first reported a position in Amedisys in Q4 2016 and held it in 35 quarters.
- Parallel Advisors's Amedisys position peaked at $887K in Q2 2025.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on Parallel Advisors's 13F filing for Q3 2025, filed 13 Nov 2025.